KRAS and cancer: The results revealed the malignant characteristics of cancer and immunity relevance and included cholangiocarcinoma, breast cancer, pancreas beta cell, MYC, keratinization, and mutation of P53 and KRAS (Figure 8A and Supplementary Figure 3A–3C).